Metastatic Breast Cancer Presenting With Severe Pulmonary Hypertension

This breast cancer diagnosis at a glance

Stage at diagnosis
Stage IV
Biomarkers
ER-positive; PR-positive.
Sex
Female
Spread to
bone; bone marrow
Treatment
chemotherapy, hormone therapy, radiation, targeted therapy and supportive care
Outcome
Responding Well

Treatment course, step by step

  1. Sildenafil was started for severe pulmonary hypertension.
  2. Weekly paclitaxel chemotherapy was started urgently.
  3. Leuprolide ovarian suppression was started.
  4. Zoledronic acid was given for bone involvement.
  5. Prednisone was given for suspected pulmonary tumor thrombotic microangiopathy or tumor emboli.
  6. Radiation therapy was completed after discharge.
  7. Palbociclib was continued with chemotherapy at the latest follow-up.

What happened, in summary

A previously healthy 36-year-old woman developed shortness of breath and chest pain after losing consciousness while driving and crashing her car. CT angiography and a ventilation-perfusion scan found no pulmonary embolism, but imaging showed abnormal thickening in both lungs. Echocardiography and right-heart catheterization confirmed severe pulmonary arterial hypertension. Spine imaging also revealed fractures and destructive lesions at several vertebrae.

She had recently been told that a screening mammogram showed a left-breast abnormality. An inpatient breast biopsy identified invasive mammary carcinoma that was estrogen-receptor positive and progesterone-receptor positive. Bone-marrow biopsy showed near-total replacement by cancer cells, confirming metastatic breast cancer. Clinicians strongly suspected pulmonary tumor thrombotic microangiopathy or tumor emboli, although pulmonary-artery cytology was negative and the diagnosis could not be proven histologically.

Sildenafil was started for pulmonary hypertension, followed urgently by weekly paclitaxel, leuprolide, and zoledronic acid. Prednisone was added for the suspected pulmonary vascular complication. Within days, her oxygen needs and cardiovascular measurements improved. Ten days after treatment began, right-ventricular size, function, and pressure had normalized. She left hospital with temporary home oxygen, later tapered off oxygen and steroids, completed radiation, and continued systemic therapy. PET imaging showed a marked response. Seven months after diagnosis, she was doing well and continuing treatment with palbociclib.

Where this story comes from

This is a lay summary of an account first published by PMC / PubMed Central. Read the original in full

How we source and attribute stories Accuracy and limitations

Collections this story belongs to

Similar breast cancer stories

These are lay summaries of published cancer stories, for information only. No two cancers behave the same way, and nothing here predicts your own diagnosis or replaces advice from your oncology team. Read the full disclaimer

Search more breast cancer stories